US Oncology Launches Oncology-Specific Service for Billing and Reimbursement
US Oncology, Inc, is launching Oncology Reimbursement Solutions (ORS), an oncology-focused billing and reimbursement service designed to increase operational efficiency and improve the economics of independent community-based oncology practices.
US Oncology, Inc, is launching Oncology Reimbursement Solutions (ORS), an oncology-focused billing and reimbursement service designed to increase operational efficiency and improve the economics of independent community-based oncology practices.
With a focus on maximizing key reimbursement metrics, ORS offers a comprehensive revenue cycle management program, a full curriculum of oncology billing and coding education, and assistance in accessing patient assistance programs. The stand-alone service provides oncologists with expertise in revenue cycle management to ensure proper reimbursement for their services.
US Oncology has customized the ORS practice management system to meet the complex needs of oncologists. The ORS technology solution supports both front and back office business functions. Benefits of the technology include efficient scheduling models; integrated claim scrubbing; payer contract management; a virtually paperless accounts receivable and denial management process; and advanced reporting and analytics.
Oncology Peer Review On-The-Go: Cancer Care Management During the COVID-19 Pandemic
October 28th 2020The newest episode of Oncology Peer Review On-The-Go speaks with 2 authors of an article from the October Issue of the journal ONCOLOGY focusing on effective cancer care management during the coronavirus pandemic.
Efficacy and Safety of Zolbetuximab in Gastric Cancer
Zolbetuximab’s targeted action, combined with manageable adverse effects, positions it as a promising therapy for advanced gastric cancer.
These data support less restrictive clinical trial eligibility criteria for those with metastatic NSCLC. This is especially true regarding both targeted therapy and immunotherapy treatment regimens.
